MRGPRX2 and Alzheimer disease: In recent years, drug discovery efforts have focused on small-molecule antagonists that inhibit MRGPRX2-mediated, non-IgE-dependent MCs degranulation as a novel strategy for treating chronic pruritus in AD (156).